|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009924,
umls-concept:C0040053,
umls-concept:C0087086,
umls-concept:C0205314,
umls-concept:C0208973,
umls-concept:C0303920,
umls-concept:C0679622,
umls-concept:C1517892,
umls-concept:C1537028,
umls-concept:C1704666,
umls-concept:C2256562
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-7-13
|
|
pubmed:abstractText |
Activated factor XIII (FXIIIa) mediates fibrinolytic resistance and is a hallmark of newly formed thrombi. In vivo imaging of FXIIIa activity could further elucidate the role of this molecule in thrombosis and other biological processes and aid in the clinical detection of acute thrombi.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
13
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
170-6
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:15210587-Animals,
pubmed-meshheading:15210587-Chlorides,
pubmed-meshheading:15210587-Contrast Media,
pubmed-meshheading:15210587-Cross-Linking Reagents,
pubmed-meshheading:15210587-Factor XIIIa,
pubmed-meshheading:15210587-Feasibility Studies,
pubmed-meshheading:15210587-Ferric Compounds,
pubmed-meshheading:15210587-Fibrin,
pubmed-meshheading:15210587-Fluorescent Dyes,
pubmed-meshheading:15210587-Humans,
pubmed-meshheading:15210587-Mice,
pubmed-meshheading:15210587-Mice, Inbred BALB C,
pubmed-meshheading:15210587-Microscopy, Fluorescence,
pubmed-meshheading:15210587-Peptide Fragments,
pubmed-meshheading:15210587-Protein Binding,
pubmed-meshheading:15210587-Spectroscopy, Near-Infrared,
pubmed-meshheading:15210587-Thrombosis,
pubmed-meshheading:15210587-Time Factors,
pubmed-meshheading:15210587-alpha-2-Antiplasmin
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi.
|
|
pubmed:affiliation |
Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, USA. fjaffer@partners.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
